Abstract
Hypothermic machine perfusion (HMP) has been demonstrated to be a more effective method for preserving livers donated after circulatory death (DCD) than cold storage (CS); however, the underlying mechanisms remain unclear. The aim of the present study was to investigate the protective effects of HMP on rat DCD livers and the possible role of the nuclear factor erythroid 2-related factor 2 (Nrf2)/antioxidant response element (ARE) signaling pathway. A total of 18 adult male rats were randomly divided into three groups: Control, HMP and CS (n=6 per group). To simulate the conditions of DCD liver transplantation, rat livers in the CS and HMP groups were subjected to 30 min warm ischemia following cardiac arrest and were then preserved by CS or HMP for 3 h. Subsequently, after 1 h of isolated reperfusion, the extent of ischemia/reperfusion injury (IRI) and cellular functions were assessed. During reperfusion, intrahepatic resistance and bile production were measured, and the perfusion fluid was collected for liver enzyme analysis. The liver tissues were then harvested for the assessment of malondialdehyde (MDA) production, superoxide dismutase (SOD) activity, ATP levels, as well as for histological analysis, immunohistochemistry and a terminal deoxynucleotidyl transferase dUTP nick end labeling assay. Finally, the expression levels of the components associated with the Nrf2-ARE signaling pathway were analyzed via western blotting and reverse transcription-quantitative polymerase chain reaction. The results of the present study revealed that, compared with in the CS group, the HMP group exhibited higher levels of ATP, bile production and SOD activity, and improved histological results; however, lower levels of liver enzymes, apoptosis and MDA were detected. Additionally, the findings of the present study also suggested that the Nrf2-ARE signaling pathway may be activated by the steady laminar flow of HMP. In conclusion, HMP may attenuate ischemia-reperfusion injury to rat DCD livers via activation of the Nrf2-ARE signaling pathway.
Keywords: hypothermic machine perfusion, cold storage, rat livers donated after cardiac death, ischemia-reperfusion injury, anti-oxidant, nuclear factor erythroid 2-related factor 2
Introduction
Liver transplantation (LT) is the only effective means of treating end-stage liver disease; however, advances in liver transplantation are restricted by the shortage of donors (1). Numerous livers donated after cardiac death (DCD) are used in clinical practice (2,3), however DCD livers are subject to prolonged warm ischemic injury, which is detrimental to liver function and may affect prognosis following transplantation (4–7). Therefore, further study into improving the quality of the DCD livers is required. Increasing evidence in liver transplant research has suggested that hypothermic machine perfusion (HMP) may be more beneficial for the quality of DCD livers than cold storage (CS) (8,9); however, the specific mechanism underlying HMP requires further investigation.
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor associated with various intracellular signaling pathways and is a sensor of oxidative stress; thus, Nrf2 serves an important role in the main defense mechanisms induced by cellular oxidative stress (10,11). Under physiological conditions, Nrf2 can achieve a stable balance in combination with Kelch-like ECH-associated protein-1 (Keap1), which can mediate the ubiquitination of the Nrf2/Keap1 complex (12–14). Oxidative and/or electrophilic stimuli may induce the dissociation of Nrf2 from Keap1. Nrf2 can then rapidly translocate to the nucleus to function as a strong transcriptional activator of the antioxidant response element (ARE) regulating the transcription of genes, including heme oxygenase-1 (HO-1), glutathione-S-transferase-1 (GST-1), NAD(P)H:quinine oxidoreductase 1 (NQO1) and glutamate cysteine ligase (GCL) (15). Numerous studies have demonstrated that the Nrf2-ARE signaling pathway serves an important role in ischemia-reperfusion injury (IRI) (16–18). In addition, Nrf2 can be activated by steady laminar flow (19,20). Based on previous research (16–21), the present study hypothesized that HMP may increase the transcription of ARE-response genes via the binding of Nrf2, and thus reduce IRI to DCD livers by attenuating oxidative stress; the underlying mechanism was also investigated in the present study.
Materials and methods
Ethics statement
The present study was conducted according to the Experimental Animal Regulations of the People's Republic of China and the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and the Guide for the Care and Use of Laboratory Animals of the USA (22), ensuring that all animals received humane care. The present study was approved by the Ethics Committee of Wuhan University (Wuhan, China).
Animals and experimental design
A total of 18 adult male Sprague-Dawley rats (age, 8 weeks; body weight, 250±10 g) were purchased from the Experimental Animal Culture Center of Hubei Centers for Disease Control (Hubei, China), and were maintained in the Animal Experimental Center of Zhongnan Hospital of Wuhan University (Wuhan, China). The rats were fed standard chow and water, and housed under standard experimental conditions (temperature: 20–25°C, humidity: 50–70%) under a 12 h light/dark cycle. To simulate DCD liver transplantation, 30 min of warm ischemia was conducted in livers (n=12, CS and HMP groups) in situ, followed by a rewarming period of 15 min prior to being connected to the isolated perfused rat liver device (IPRL). To investigate the protective effects of HMP on the DCD livers, the extent of graft injury in healthy livers (non-DCD, no IRI) was compared with DCD livers preserved by either CS or HMP (described below). Following graft preservation, to simulate the period of rewarming during re-implantation, all the livers were left untouched on a petri dish at room temperature for ~15 min prior to reperfusion (23).
Then, in order to analyze reperfusion injury, livers were re-perfused in the isolated perfusion rat liver model for 1 h following graft preservation within the CS and HMP groups, and the same is true for the control group. For this purpose, the following experimental groups were selected: i) Control group (n=6), livers without warm ischemia and subsequent underwent 1 h reperfusion prior to sample collection; ii) CS group (n=6), DCD livers that underwent CS for 3 h, followed by 1 h reperfusion in vitro and the iii) HMP group (n=6), in which DCD livers were connected to the HMP system. HMP was performed via the portal vein for 3 h, followed by 1 h reperfusion in vitro.
Modeling procedure
Rats were anesthetized via an intraperitoneal injection of 1% sodium pentobarbital (30 mg/kg; Sinopharm Chemical Reagent Co., Ltd., Shanghai, China). A midline incision was conducted to provide entry into the abdominal cavity. The liver was carefully separated from the attached round ligament. Subsequently, the common bile duct was cannulated using a guided epidural tube (Jiangsu Changfeng Medical Industry, Co., Ltd. (Jiangsu, China) to collect bile during reperfusion. In the experimental groups, DCD was induced by hypoxia via an incision of the diaphragm without portal clamping prior to heparinization, as described below. The onset of in situ-warm ischemia was determined to be the point of the cardiac arrest, which was maintained for 30 min at 29±1.5°C. The control group did not experience the warm ischemia and the other operations were the same as the experimental groups. Subsequently, the hepatic artery was ligated and then 2 ml saline containing 100 IU heparin (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) was injected via the right iliac vein. A total of 20 ml (4°C) histidine-tryptophan-ketoglutarate (HTK; Dr. Franz Köhler Chemie GmbH, Bensheim, Germany) solution was used to rinse the liver via the portal vein, which was cannulated using a self-made polyethylene (PE) catheter (outer diameter, 2.1 mm, inner diameter, 1.8 mm) (24). Finally, the liver was harvested and a PE catheter (internal diameter, 3 mm) was used to cannulate the suprahepatic inferior vena cava for collection of hepatic effluent.
CS model establishment
Following the modeling procedure, the liver was stored in the HTK solution at 0–4°C for 3 h to maintain a static state without any treatment. Following preservation, the CS group was simulated the period of rewarming for a 15 min and then connected to the IPRL, which is the reperfusion device used to assessment of IRI severity against livers (described below).
HMP and the IPRL model system
HMP and IPRL was performed as previously described (25,26) with certain modifications. The HTK solution served as a perfusate for HMP; the devices employed for perfusion were maintained in an ice water solution (0–4°C). Following collection of the livers, the samples from the HMP group were connected to the perfusion device and perfused via the portal vein. The perfusion flow was maintained at 0.23 ml/min/g (23). The perfusate was oxygenated with air and recirculated for 3 h (perfusate volume, 100 ml). Following preservation, the caudate lobe of the rat livers of the CS and HMP groups was ligated and harvested to obtain samples prior to reperfusion. The remaining rat liver tissues in the three groups were then weighed and connected via the portal vein to the IPRL system for reperfusion. IPRL is an in vitro system that simulates physiological and pathophysiological conditions of reperfusion in liver transplantation and is often used as a tool for the assessment of IRI severity against livers (27).
The same perfusion device was used for HMP, as well as for the 1 h reperfusion period (n=12, CS and HMP groups). A detailed description of the HMP and IPRL system is given in as described in a previous study (26). Krebs-Henseleit buffer (Macgene™ M&C Genetechnolgy, Beijing, China) with 4% dextran was used as a perfusate for reperfusion (28). The temperature of the perfusate was maintained at 36–37°C during reperfusion and oxygenated to maintain PO2 >500 mmHg under the effect of mixed gas (95% oxygen and 5% carbon dioxide). The flow of portal venous perfusion was maintained at 3 ml/min/g (29) and recirculated for 1 h (perfusate volume, 250 ml).
Assessment of IRI using the IPRL system
During reperfusion, which was performed for 1 h, intrahepatic resistance (IHR) was recorded by the portal pressure and portal flow and the perfusate was collected per 15 min. Intrahepatic resistance was calculated according to the following formula: Intrahepatic resistance (mmHg/ml/min/g liver)=portal pressure (10.3 mm Hg)/portal flow (ml/min/g liver) (30). Hepatic effluent was obtained from the perfusion fluid via the PE catheter every 15 min. Samples were centrifuged at 14,000 × g and 4°C for 5–10 min and the supernatant was collected and stored at −80°C prior to the determination of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities. The enzyme activities were assessed using ALT (cat. no. C009-2), AST (cat. no. C010-2) and LDH assay kits (cat. no. A020-2; all Nanjing Jiancheng Bioengineering Institute), according to the manufacturer's protocol. As the density of bile was equal to the water (23,31), bile production was measured at 60 min by weighing the guided epidural tube in which bile was collected from the common bile duct. Then, the bile flow was gravimetrically estimated and expressed as µl/h/g liver (26).
Superoxide dismutase (SOD) activity and malondialdehyde (MDA) content
Frozen liver samples were lysed with 0.05 M Tris. HCl (Beijing Biotopped Science & Technology Co., Ltd., Being, China) extraction buffer on ice. The cell lysates were centrifuged at 4°C 12,000 × g for 10 min. The resulting cell lysates were used to assess the SOD activity and MDA content. To measure total SOD activity, a SOD kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) was employed according to the manufacturer's protocols. MDA content was assessed with an MDA assay kit (Nanjing Jiancheng Bioengineering Institute) based on the products of membrane lipid peroxidation, which are important indicators of oxidative damage during hepatic IRI.
ATP extraction and measurement
The hepatic concentration of ATP served as an indicator of the energy status of grafts following 1 h of ex situ reperfusion. The ATP content of the tissue was measured using an ATP assay kit (Nanjing Jiancheng Bioengineering Institute) according to the manufacturer's protocols. ATP levels were expressed as µmol/g protein.
Histological analysis
Following reperfusion, about 0.25 g liver samples were fixed with 10% buffered formalin for 24 h at room temperature (pH=7.2; cat. no. G2161; Beijing Solarbio Science & Technology, Co., Ltd., Beijing, China), embedded in paraffin and cut into 5-µm sections for histological analysis via hematoxylin-eosin staining (H&E; hematoxylin staining for 5–15 min and eosin staining for 1–3 min; all performed at room temperature). Sections were analyzed under a confocal microscope (magnification, ×200; Nikon A1R/A1; Nikon Corporation, Tokyo, Japan) and images were obtained. A total of 6 fields of view per section were randomly selected for the assessment of liver damage. Numerical assessment of liver damage was conducted according to the histological criteria for assessment of liver damage (32).
Immunohistochemistry of Nrf2
Following reperfusion, a portion of the livers were fixed with 10% buffered formalin for 24 h at room temperature (pH=7.2; cat. no. G2161; Beijing Solarbio Science & Technology, Co., Ltd., Beijing, China), and then embedded in paraffin, sliced, dewaxed (Dewaxing was routinely performed at 60°C for 20 min, and immediately xylene 1–3 for 10 min, respectively. However certain sections prepared on the day could be treated at 60°C for 3–4 h), and hydrated conventionally using an ethanol gradient (from high to low). The tissues were cut into 4-µm sections and mounted on glass slides. After 30 min of blocking at room temperature with 5% bovine serum albumin (Beijing Solarbio Technology Co., Ltd., Beijing, China), the samples were incubated with rabbit anti-Nrf2 antibody (1:1,000; cat. no. 16396-1-AP; Wuhan Sanying Biotechnology, Wuhan, China) overnight at 4°C. The samples were then incubated for 1 h at room temperature with a horseradish peroxidase-conjugated goat anti-rabbit IgG (1:3,000; cat. no. GB23303; Wuhan Goodbio Technology Co., Ltd., Wuhan, China). Subsequently, the samples were incubated with 3,3′-diaminobenzidine chromogen (DAB; Maixin-Bio Ltd.) at room temperature for 5 min, and then blocked on a coverslip. Any brown and yellow staining was considered to indicate positive Nrf2 expression, as visualized under a light microscope (magnification, ×200, Leica DM2000; Leica Microsystems GmbH, Wetzlar, Germany). A total of 5 visual fields were randomly selected for analysis.
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
Total RNA was isolated from the liver specimens using TRIzol® reagent (Thermo Fisher Scientific Inc., Waltham, MA, USA) according to the manufacturer's protocols. RNA was reverse transcribed into cDNA using the Easy Script One-Step gDNA Removal and cDNA Synthesis Super Mix (Beijing TransGen Biotech, Co., Ltd., Beijing, China). Total RNA (1 µg), Random primer (0.1 µg/µl), 2X ES Reaction Mix (10 µl), RI Enzyme Mix (1 µl), gDNA Remover (1 µl) were employed; the solution was made up to 20 µl with water (RNase-free). RT reactions were performed under the following conditions: 42°C for 1 h and 75°C for 5 min. The primers were synthesized by Shanghai ShineGene Molecular Biotech, Inc. (Shanghai, China; Table I). qPCR analysis was performed with the SYBR® Select Master Mix (Applied Biosystems; Thermo Fisher Scientific, Inc.) in a StepOnePlus Real-Time PCR system (Applied Biosystems; Thermo Fisher Scientific, Inc.) to determine the mRNA expression levels of Nrf2, HO-1, NQO1, GST-1, GCL and β-actin. The thermocycling conditions were as follows: 50°C for 2 min, 95°C for 10 min, followed by 40 cycles of 95°C for 10 sec and 60°C for 30 sec. Expression levels were normalized to β-actin, which was measured on the same plate; the differences were calculated via the 2−ΔΔCq method (33,34).
Table I.
Gene | Sequence (5′-3′) |
---|---|
NRF2 | |
F | GAGATATACGCAGGAGAGGG |
R | CTTTTCAGAAGATGGAGGTTT |
HO-1 | |
F | GAAGGCTTTAAGCTGGTGATG |
R | GGCTGGTGTGTAAGGGATGG |
NQO1 | |
F | GGCTGGTTTGAGAGAGTGCT |
R | ACGTTCATGTCCCCGTGG |
GST-1 | |
F | CACAGAGACACAGCACAGC |
R | CCTTCCACCTCCAAAACAG |
GCL | |
F | GCAGCTCATTGGTTCATCT |
R | TCGTCCCTTCAAAGTCTTT |
β-actin | |
F | CCCTGGCTCCTAGCACCAT |
R | CACAGAGTACTTGCGCTCAGGA |
HO-1, heme oxygenase 1; GCL, glutamate cysteine ligase; GST-1, glutathione-S-transferase-1; NQO1, NAD(P)H:quinine oxidoreductase; NRF2, nuclear factor erythroid 2-related factor 2; F, forward; R, reverse.
Terminal deoxynucleotidyl-transferase-mediated dUTP nick-end labeling (TUNEL) assay
Apoptosis was determined via a TUNEL assay (One-Step TUNEL Apoptosis assay kit, Beyotime Institute of Biotechnology, Haimen, China) according to the manufacturer's protocols. Briefly, 4-µm thick paraffin sections, which contained the liver tissues were deparaffinized and hydrated, then treated with proteinase K for 20 min and subsequently incubated with a mixture of fluorescent labeling solution and TdT enzyme at 37°C for 1 h in a humidified atmosphere. The samples were washed in 1XPBS and mounted in mounting media containing DAPI at room temperature for 10 min without the light. Blue ray was chosen as the exciting light, the wavelength is 420–485 nm. GFP was excited and emitted 515 nm green fluorescence. Liver cells, which expressed GFP emitted green fluorescent. The total hepatocytes and TUNEL-positive cells were detected in 4–5 randomly selected fields (magnification, ×200) for each liver section using a fluorescence microscope (Olympus X71; Olympus Corporation, Tokyo, Japan). The apoptotic rate was calculated according to the formula: Number of TUNEL positive cells/number total cells × % (35,36). The TUNEL positive cells were calculated by three different authors.
Western blot analysis
Prior to and following reperfusion, all collected liver tissues were rapidly dissected within 5 min and stored at −80°C for cryopreservation. In order to extract the total proteins, the liver tissue was thawed and homogenized in radioimmunoprecipitation assay buffer containing a protease inhibitor (cat. no. G2002; Wuhan Servicebio Co., Ltd., Wuhan, China) and then centrifuged at 20,000 × g for 10 min at 4°C. Following collection of the supernatants and measuring the total protein concentration, 30 mg protein, which was calculated by the bicinchoninic acid kit (cat. no. G2026; Wuhan Servicebio Co., Ltd., Wuhan, China) was separated by 10% SDS-PAGE and transferred to polyvinylidene difluoride membranes (EMD Millipore, Billerica, MA, USA). The membranes were blocked in 5% skimmed milk for 1 h at room temperature. The blots were then incubated in 4°C for 12 h with the following antibodies: Rabbit anti-Nrf2 antibody (1:1,000; cat. no. 16396-1-AP; Wuhan Sanying Biotechnology), rabbit anti-HO-1 antibody (1:2,000; cat. no. 27282-1-AP Wuhan Sanying Biotechnology), rabbit anti-NQO1 antibody (1:200; cat. no. bs-23407R Beijing Biosynthesis Biotechnology Co., Ltd., Beijing, China), rabbit anti-Toll-like receptor 4 (TLR4) antibody (cat. no. 19811-1-AP, 1:1,000; Wuhan Sanying Biotechnology), rabbit anti-B-cell lymphoma 2 (Bcl-2) antibody (1:1,000; cat. no. 10435-1-AP; Wuhan Sanying Biotechnology), rabbit anti-Bcl-2-associated X (Bax) antibody (1:1,000; cat. no. 60267-1-Ig; Wuhan Sanying Biotechnology) and anti-β-actin antibody (1:3,000; ProteinTech Group, Inc., Chicago, IL, USA). Following incubation for 1 h at room temperature with horseradish peroxidase-conjugated goat anti-rabbit IgG (1:3,000; cat. no. GB23303; Wuhan Goodbio Technology Co. Ltd., Wuhan, China), the proteins were detected using an enhanced chemiluminescence reagent (cat. no. G2020; Wuhan Servicebio Co., Ltd., Wuhan, China) followed by exposure to X-ray film. Quantification of protein bands was performed using ImageJ v1.42q software (National Institutes of Health, Bethesda, MA, USA).
Statistical analysis
All data were analyzed using SPSS 16.0 statistical software for Windows (SPSS, Inc., Chicago, IL, USA) by one-way analysis of variance with Tukey's post-hoc test. All results are presented as the mean ± standard deviation (n=6 for each experiment). P<0.05 was considered to indicate a statistically significant difference.
Results
HMP leads to decreased enzymatic levels, reduced intrahepatic resistance and improved liver function compared with the CS group
The activities of ALT and AST enzymes in the perfusate were used to assess the severity of IRI to DCD livers. In the present study, the levels of liver enzymes ALT and AST in the perfusate of the CS group increased significantly compared with in the control group (P<0.01; Fig. 1A and B, respectively). The HMP group exhibited significantly decreased levels of ALT and AST compared with in the CS group (P<0.01; Fig. 1A and B). Additionally, the intrahepatic resistance of livers in the control group was low during reperfusion; however, in the CS group, it was significantly higher compared with in the HMP group at each analyzed time point (P<0.01; Fig. 1C). In addition, bile production in the CS group was significantly lower compared with in the control group (P<0.01; Fig. 1D). Furthermore, bile production decreased in the HMP group; however, no significant difference was observed compared with in the CS group (P>0.05). Visual and numerical analyses of the histological images indicated that there were few observable abnormalities in the livers of the control group (Fig. 2). Conversely, in the CS group, histological analysis revealed significant congestion of the hepatic sinusoid, vacuolar degeneration and necrosis (P<0.01; Fig. 2A-C). Additionally, significantly attenuated liver damage was observed in the HMP group compared with in the CS group (P<0.05; Fig. 2A-C).
HMP reduces hepatic oxidative stress, inflammation and apoptosis
The present study analyzed the typical biochemical markers of oxidative stress to further investigate the effects of HMP on the IRI livers. Oxidative stress has been considered to be an important factor leading to IRI. The SOD activities and expression levels of MDA of the tissues were presented in Fig. 3A and B. Compared with the control group, SOD activity in the CS group was significantly decreased (P<0.01), and the expression levels of MDA were significantly increased (P<0.01). The results of the present study indicated that HMP treatment may significantly decrease the MDA expression levels (P<0.01) and significantly increase the SOD activity (P<0.01); opposite trends to those observed in the CS group. These results suggested that HMP may attenuate oxidative stress. In addition, the ATP content in the liver was also measured to analyze liver function. As presented in Fig. 3C, within the CS group, the ATP content was significantly lower compared with the control group (P<0.01); however, HMP treatment significantly increased the ATP content compared with in the CS group. (P<0.01).
Oxidative stress can also induce hepatic inflammation and apoptosis (37,38). Therefore, the present study investigated the expression levels apoptosis-associated proteins in the liver (Fig. 3D). The ratio of Bcl-2 to Bax is also important in determining susceptibility of cells to apoptosis (39). The overexpression of Bax revealed that apoptosis was promoted in response to a death-inducing signal, which suggested its role as an apoptosis agonist (40). Bcl-2 overexpression has been associated with heterodimerization with Bax and reduced levels of apoptosis (41). In addition, TLR4 has been reported to be an important marker of inflammation (42). As presented in Fig. 3E, the ratio of Bcl-2 to Bax was significantly downregulated in the CS group and significantly upregulated in the HMP group (P<0.01). The protein expression levels of TLR4 were significantly increased in the CS group and significantly decreased in the HMP group (P<0.01; Fig. 3F). Furthermore, the present study revealed that, compared with the control group, the rate of apoptosis in the CS group was significantly increased (P<0.01; Fig. 4); however, treatment with HMP was associated with significantly reduced rates of apoptosis.
HMP activates the Keap1/Nrf2-ARE antioxidant pathway in DCD rat livers
Nrf2 serves an important role in the main defense mechanisms induced by cellular oxidative stress (10,11). Therefore, the present study investigated whether HMP conferred protection against IRI to rat DCD livers via alterations in Nrf2 expression. The results reveled that compared with the control group, the expression levels of Nrf2 in the CS group were significantly decreased (P<0.05); however, the HMP group exhibited a significant increase compared with in the CS group (P<0.01; Fig. 5A and B). In addition to the expression levels of Nrf2 protein, NQO1 protein expression levels in the CS and HMP groups demonstrated opposing expression patterns (P<0.05; Fig. 5A and B). Notably, despite the significant increase in HO-1 protein expression levels in the CS group compared with the control, the HMP group exhibited a significant decrease compared with the CS group (P<0.01; Fig. 5A and B).
Reperfusion injury due to toxic reactive oxygen species generated upon reintroduction of blood flow and oxygen supply to ischemic tissues is the main cause of DCD liver injury (43). Therefore, the expression levels of proteins in the presence or absence of reperfusion were investigated in the present study to determine whether HMP may activate the Nrf2-ARE signaling pathway.
The results of the present study revealed that the expression levels of Nrf2, NQO-1 and HO-1 were all been significantly upregulated during reperfusion in both the CS and HMP groups (P<0.05; Fig. 5C and D). In addition, the induction of Nrf2 (0.392±0.137 vs. 0.912±0.122; P<0.0001) and NQO-1 (0.342±0.057 vs. 1.076±0.102; P<0.0001) expression in the presence of IRI was significantly higher within the HMP group compared with the induction of Nrf2 (0.300±0.079 vs. 0.529±0.075; P=0.007) and NQO-1 (0.287±0.104 vs. 0.575±0.078; P<0.0001) expression in the CS group. All this suggested that the effects of HMP on oxidative stress may occur via activation of the Nrf2-ARE signaling pathway (P<0.05; Fig. 5C and D).
Additionally, the mRNA expression levels of Nrf2, HO-1, NQO1, GST-1, and GCL in the liver were investigated via RT-qPCR (Fig. 6). The results of the present study revealed that except for HO-1, the mRNA expression levels of the other ARE-regulated genes were significantly enhanced in the HMP group compared with the CS group (P<0.05; Fig. 6). This suggested that additional regulatory elements may be involved in the activation of HO-1 in the CS group; however, the activation of Nrf2 and other ARE-regulated genes, as well as the inhibition of oxidative stress markers, including MDA in the HMP group, suggested that HMP may be responsible for the increase in antioxidative ability of cells by activating the Nrf2-ARE signaling pathway.
Furthermore, previous studies have confirmed that Nrf2 may be activated in endothelial cells by steady laminar flow (19,20). Thus, immunohistochemistry was conducted to assess whether steady laminar flow provided by HMP may induce the expression levels of Nrf2 (Fig. 7). The results revealed that within the HMP group, Nrf2 expression was significantly increased in the periportal regions of livers when compared with the CS group (P<0.01), This suggested that Nrf2 in hepatocytes and liver sinusoidal endothelial cells around periportal regions may be induced by steady laminar flow.
Discussion
HMP has become a topic of interest in the past decade, with regards to maintaining the quality of liver grafts, particularly DCD livers (44); however, the protective mechanisms of HMP require further investigation. The present study investigated the benefits of HMP in mitigating injuries from preservation methods with a specific focus on oxidative stress in DCD livers. The Nrf2 signaling pathway is an important mediator of the antioxidant system in mammals (15). In the present study, it was demonstrated that HMP may reduce IRI to DCD livers via activation of the Nrf2-ARE signaling pathway.
Additionally, the present study demonstrated that, compared with the CS group, the HMP group revealed improved hepatocellular functions and overall tissue viability, as indicated by improved ATP and bile production, and lower ALT and AST levels. Bile production between the CS group and HMP group did not exhibit significant differences under the HMP condition, and this may have been due to the delivery of nutrients and oxygen via the portal vein rather than the hepatic artery, which is the only way oxygen is delivered in the physiological state (23,31). In HMP group the liver was perfused through portal vein, therefore cholangiocytes may be more sensitive to ischemic injury and would influence the production of bile. The congestion and vacuolar degeneration observed in the histological sections were considered to be possible causes for microcirculation dysfunction. In addition to the improved histological findings, the levels of intrahepatic resistance in the HMP group were significantly lower compared with in the CS group.
Numerous mechanisms underlying IRI in the DCD liver grafts have been reported, including oxidative stress (45). In the present study, the levels of SOD activity represented the antioxidant capacity and MDA expression levels reflected the degree of oxidative damage to cells. The present study observed a significant reduction in the levels of MDA within the HMP group, indicating that oxidative damage to the graft may be attenuated following HMP preservation compared with in the CS group. Furthermore, an increase in the activity of SOD following reperfusion was observed during HMP preservation, which indicated a cellular attempt to ameliorate oxidative damage. Overall, the findings of the present study suggested that HMP may be a better strategy of preservation than CS and may exert protective effects against IRI on the DCD liver.
Oxidative stress may also induce hepatic inflammation and apoptosis (37–39). In addition, TLR4 is an important marker of inflammation and is activated during hepatic IR, as well as IRI in multiple organs; the importance of TLR4 in IRI has also been verified in a transplant model (46). The results of the present study indicated that the protein expression levels of TLR4 in the CS group were significantly higher than the control group; however, the HMP group exhibited lower expression levels of TLR4 than the CS group. This result suggested that reductions in oxidative stress may reduce the inflammation of DCD liver. In addition, Bax and Bcl-2 are important markers of apoptosis (40); Bax is a proapoptotic protein, while Bcl-2 is an antiapoptotic protein (41). Thus, the protein expression levels of Bcl-2 and Bax following reperfusion were investigated in the present study to determine whether apoptosis may be inhibited. The alterations of the Bcl-2/Bax ratio in the CS and HMP groups indicated that HMP may attenuate hepatocyte apoptosis. TUNEL staining also indicated the extent of hepatocyte apoptosis in the present study. When investigations were performed with HMP instead of CS to preserve the liver, the rate of hepatocyte apoptosis decreased significantly in the present study. This indicated that, with the decline of liver oxidative stress, liver inflammation and apoptosis may be attenuated.
Previous studies have suggested a role of Nrf2 in antioxidative and anti-apoptotic process functions in IRI (16,47). Therefore, the present study proposed that the activity of Nrf2 may serve a role in the protective effects of HMP against IRI; the protein and mRNA expression levels of Nrf2 between the HMP and CS groups were investigated. Significantly higher expression levels were observed in the HMP group compared with in the CS, which indicated that HMP may have induced the expression of Nrf2. Additionally, immunohistochemistry analysis demonstrated that the expression of Nrf2 in the pericentral region was notably increased following HMP treatment. The Nrf2 signaling pathway mainly involves Nrf2, Keap1 and ARE. Following dissociation from Keap1, activated Nrf2 enters the nucleus and binds to the ARE sequence by combining with MAF protein to form heterodimers. Through this binding process, Nrf2 regulates the transcription of antioxidative-associated genes (15). Following reperfusion, the expression of antioxidant molecules, including GST-1, NQO1 and GCL, which are the target genes of Nrf2, are increased in the livers of the HMP group. As described in the previous results, compared with the control group, the expression levels of HO-1 protein appeared to increase more than in the HMP group. The reason for this phenomenon may be that the regulation of HO-1 gene expression occurs at the transcriptional level. The regulatory elements of the gene include not only components associated with the Nrf2-ARE signaling pathway, but also the activator protein-1 binding site, nuclear factor-κB binding site, a heat-shock element and hypoxic response elements. Activation of the HO-1 gene results from the binding of various transcription factors to these regulatory elements (48–50). There may be other potential mechanisms underlying the increased protein expression levels of HO-1 in the CS group.
Providing that reperfusion is the main cause of DCD liver injury, the present study also investigated the expression of proteins associated with the Nrf2-ARE signaling pathway prior to and following reperfusion to determine whether HMP may activate this signaling pathway. The protein expression levels of the Nrf2-ARE signaling pathway were significantly different prior to and following reperfusion. In addition, the higher end protein level quantification values of Nrf2 and NQO1 in the HMP group compared with the CS group following reperfusion indicated that the effect of HMP was more notable than CS treatment. In addition, the present study revealed that HMP may be able to reduce the extent of apoptosis and inflammation in accordance with alterations in Nrf2 expression. This indicated that the Nrf2-ARE signaling pathway may serve an important role in the molecular mechanism underlying the protective effects of HMP.
Furthermore, previous studies have confirmed that Nrf2 may be activated by steady laminar flow (19,20,51). When endothelial cells come into contact with the flowing blood, they experience different types of stress. In contrast with disturbed blood flow, steady laminar flow serves positive roles, and in this situation the activation of protective factors including Nrf2 is dominant (20). Based on previous studies, steady laminar flow leads to sustained high shear stress, and flow shear stress were considered to produce antioxidant, antiapoptotic, anti-inflammatory, and antiproliferative effects (20,51). Therefore, the results of the present study that HMP demonstrated decreased enzymatic levels, reduced intrahepatic resistance and improved histological findings compared with CS, suggest that steady laminar flow may provides a supply of metabolic substrates and removes byproducts, recreating the normal circulation, which corresponds with the previous studies (52). Then, Hsieh et al (51) demonstrated that shear stress can increase Nrf2 protein expression and induce Nrf2 translocation into nuclei; in addition, shear stress also increased the ARE-binding activity of Nrf2, and a number of antioxidant genes, including HO-1, NQO1 and GST-1, are upregulated in endothelial cells under laminar shear stress. The activation of Nrf2 is essential for the antioxidant function of shear stress, and the effector proteins HO-1 and NQO1 have been demonstrated to respond to flow shear stress in vascular endothelial cells (19). However the detailed mechanism of the activation of Nrf2 and how the antioxidant ability of flow shear stress is regulated remains to be studied. Additionally, as this perspective suggests, immunohistochemistry analysis in our study also demonstrated that the expression of Nrf2 which may be activated in endothelial cells by steady laminar flow, was notably increased in the pericentral region following HMP treatment. As a result of all this information, HMP preservation was concluded to dilate the intrahepatic vasculature and improve microcirculation, resulting in steady laminar flow during reperfusion, which was the activator of Nrf2-ARE pathway.
In the present study, the alterations of NRF2-ARE pathway by different storage method during simulated DCD liver transplantation were investigated. NRF2 is a key molecule in anti-oxidative stress (10,11). Combined with the authors' studies, this may suggest that the NRF2-ARE signaling pathway may be a novel pharmacological target for improving DCD liver quality. However, the present study also has some deficiencies. Due to the lack of a murine IPRL system, the present study failed to use knockout mice, which may need further study. Organ preservation has always been a bottleneck that affected the development of transplantation. How to preserve organs more effectively has always been a study hotspot in the field of transplantation. In addition, although HMP is the routine method for clinical donated kidney protection, which kind of preservation method is more effective in the liver remains unknown. It was demonstrated that the possible mechanism of HMP to protect the DCD liver maybe result from the activation of NRF2-ARE pathway, but the specific mechanism needs to be further research by using the knockout mice. In addition, clinical trials may focus on drugs associated with NRF2 pathway to improve DCD liver and the outcome of the transplant. These are possible future research areas. In conclusion, the protective effects of HMP on the DCD liver may arise from alterations in Nrf2 expression levels. Therefore, via the activation of Nrf2 and its function of binding to the ARE sequence, HMP may serve a role against oxidative stress to protect the DCD liver from IRI.
Acknowledgements
The authors would like to thank the professors and students from Zhongnan Hospital of Wuhan University and Institute of Hepatobiliary Diseases of Wuhan University, who participated in this study.
Funding
The present study was supported by the National Natural Science Foundation of China (grant no. U1403222).
Availability of data and materials
All data generated or analyzed during this study are included in this published article.
Authors' contributions
SX and QY contributed the central idea, analyzed most of the data, and wrote the initial draft of the paper. WH, XZ, ZZ, YX and YW contributed to refining the ideas. SX, QY, WH, XZ, ZT and SF carried out additional analyses and finalizing this paper.
Ethics approval and consent to participate
The present study was conducted according to the Experimental Animal Regulations of the People's Republic of China and the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health, ensuring that all animals received humane care. The present study was approved by the Ethics Committee of Wuhan University (Wuhan, China).
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
References
- 1.O'Leary JG, Lepe R, Davis GL. Indications for liver transplantation. Gastroenterology. 2008;134:1764–1776. doi: 10.1053/j.gastro.2008.02.028. [DOI] [PubMed] [Google Scholar]
- 2.Monbaliu D, Pirenne J, Talbot D. Liver transplantation using donation after cardiac death donors. J Hepatol. 2012;56:474–485. doi: 10.1016/j.jhep.2011.07.004. [DOI] [PubMed] [Google Scholar]
- 3.Neyrinck A, Van Raemdonck D, Monbaliu D. Donation after circulatory death: Current status. Curr Opin Anaesthesiol. 2013;26:382–390. doi: 10.1097/ACO.0b013e328360dc87. [DOI] [PubMed] [Google Scholar]
- 4.Jay CL, Lyuksemburg V, Ladner DP, Wang E, Caicedo JC, Holl JL, Abecassis MM, Skaro AI. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: A meta-analysis. Ann Surg. 2011;253:259–264. doi: 10.1097/SLA.0b013e318204e658. [DOI] [PubMed] [Google Scholar]
- 5.Fujita S, Mizuno S, Fujikawa T, Reed AI, Kim RD, Howard RJ, Hemming AW. Liver transplantation from donation after cardiac death: A single center experience. Transplantation. 2007;84:46–49. doi: 10.1097/01.tp.0000267424.88023.7b. [DOI] [PubMed] [Google Scholar]
- 6.Manzarbeitia CY, Ortiz JA, Jeon H, Rothstein KD, Martinez O, Araya VR, Munoz SJ, Reich DJ. Long-term outcome of controlled, non-heart-beating donor liver transplantation. Transplantation. 2004;78:211–215. doi: 10.1097/01.TP.0000128327.95311.E3. [DOI] [PubMed] [Google Scholar]
- 7.Morrissey PE, Monaco AP. Donation after circulatory death: Current practices, ongoing challenges, and potential improvements. Transplantation. 2014;97:258–264. doi: 10.1097/01.TP.0000437178.48174.db. [DOI] [PubMed] [Google Scholar]
- 8.Henry SD, Guarrera JV. Protective effects of hypothermic ex vivo perfusion on ischemia/reperfusion injury and transplant outcomes. Transplantation Rev (Orlando) 2012;26:163–175. doi: 10.1016/j.trre.2011.09.001. [DOI] [PubMed] [Google Scholar]
- 9.Schreinemachers MJ, Doorschodt BM, van Gulik TM. Machine perfusion preservation of the liver: A worthwhile clinical activity? Curr Opin Organ Transplant. 2007;12:224–230. doi: 10.1097/MOT.0b013e32814e6bc2. [DOI] [PubMed] [Google Scholar]
- 10.Ma Q, He X. Molecular Basis of Electrophilic and Oxidative Defense: Promises and Perils of Nrf2. Pharmacol Rev. 2012;64:1055–1081. doi: 10.1124/pr.110.004333. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 2007;47:89–116. doi: 10.1146/annurev.pharmtox.46.120604.141046. [DOI] [PubMed] [Google Scholar]
- 12.Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999;13:76–86. doi: 10.1101/gad.13.1.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Kang MI, Kobayashi A, Wakabayashi N, Kim SG, Yamamoto M. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc Natl Acad Sci USA. 2004;101:2046–2051. doi: 10.1073/pnas.0308347100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Zhang DD, Hannink M. Distinct cysteine residues in keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventiveagents and oxidative stress. Mol Cell Biol. 2003;23:8137–8151. doi: 10.1128/MCB.23.22.8137-8151.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Kurokawa H, Motohashi H, Sueno S, Kimura M, Takagawa H, Kanno Y, Yamamoto M, Tanaka T. Structural basis of alternative DNA recognition by Maf transcription factors. Mol Cell Biol. 2009;29:6232–6244. doi: 10.1128/MCB.00708-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Kudoh K, Uchinami H, Yoshioka M, Seki E, Yamamoto Y. Nrf2 activation protects the liver from ischemia/reperfusion injury in mice. Ann Surg. 2014;260:118–127. doi: 10.1097/SLA.0000000000000287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Lee LY, Harberg C, Matkowskyj KA, Cook S, Roenneburg D, Werner S, Johnson J, Foley DP. Overactivation of the nuclear factor (erythroid-derived 2)-like 2-antioxidant response element pathway in hepatocytes decreases hepatic ischemia/reperfusion injury in mice. Liver Transplant. 2016;22:91–102. doi: 10.1002/lt.24303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Tanaka Y, Maher JM, Chen C, Klaassen CD. Hepatic ischemia-reperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice. Mol Pharmacol. 2007;71:817–825. doi: 10.1124/mol.106.029033. [DOI] [PubMed] [Google Scholar]
- 19.Fukuda Y, Kaishima M, Ohnishi T, Tohyama K, Chisaki I, Nakayama Y, Ogasawara-Shimizu M, Kawamata Y. Fluid shear stress stimulates MATE2-K expression via Nrf2 pathway activation. Biochem Biophys Res Commun. 2017;484:358–364. doi: 10.1016/j.bbrc.2017.01.124. [DOI] [PubMed] [Google Scholar]
- 20.Nigro P, Abe J, Berk BC. Flow shear stress and atherosclerosis: A matter of site specificity. Antioxid Redox Signal. 2011;15:1405–1414. doi: 10.1089/ars.2010.3679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Zakkar M, Angelini GD, Emanueli C. Regulation of vascular endothelium inflammatory signalling by shear stress. Curr Vasc Pharmacol. 2016;14:181–186. doi: 10.2174/1570161114666151202205139. [DOI] [PubMed] [Google Scholar]
- 22.National Research Council, corp-author. Guide for the care and use of laboratory animals. 8th edition. The National Academies press; Washington, DC: 2011. [Google Scholar]
- 23.Carnevale ME, Balaban CL, Guibert EE, Bottai H, Rodriguez JV. Hypothermic machine perfusion versus cold storage in the rescuing of livers from non-heart-beating donor rats. Artif Organs. 2013;37:985–991. doi: 10.1111/aor.12235. [DOI] [PubMed] [Google Scholar]
- 24.Rodriguez J, Guibert EE, Quintana A, Scandizzi A, Almada L. Role of sodium nitroprusside in the improvement of rat liver preservation in University of Wisconsin solution: A study in the isolated perfused liver model. J Surg Res. 1999;87:201–208. doi: 10.1006/jsre.1999.5750. [DOI] [PubMed] [Google Scholar]
- 25.Dutkowski P, Schönfeld S, Odermatt B, Heinrich T, Junginger T. Rat liver preservation by hypothermic oscillating liver perfusion compared to simple cold storage. Cryobiology. 1998;36:61–70. doi: 10.1006/cryo.1997.2066. [DOI] [PubMed] [Google Scholar]
- 26.Zeng C, Hu X, He W, Wang Y, Li L, Xiong Y, Ye Q. Hypothermic machine perfusion ameliorates inflammation during ischemia-reperfusion injury via sirtuin-1-mediated deacetylation of nuclear factor-κB p65 in rat livers donated after circulatory death. Mol Med Rep. 2017;16:8649–8656. doi: 10.3892/mmr.2017.7738. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Schlegel A, Kron P, Graf R, Dutkowski P, Clavien PA. Warm vs. cold perfusion techniques to rescue rodent liver grafts. J Hepatol. 2014;61:1267–1275. doi: 10.1016/j.jhep.2014.07.023. [DOI] [PubMed] [Google Scholar]
- 28.Pizarro MD, Rodriguez JV, Mamprin ME, Fuller BJ, Mann BE, Motterlini R, Guibert EE. Protective effects of a carbon monoxide-releasing molecule (CORM-3) during hepatic cold preservation. Cryobiology. 2009;58:248–255. doi: 10.1016/j.cryobiol.2009.01.002. [DOI] [PubMed] [Google Scholar]
- 29.Srinivasan PK, Yagi S, Doorschodt B, Nagai K, Afify M, Uemoto S, Tolba R. Impact ofvenous systemic oxygen persufflation supplemented with nitric oxide gas on cold-stored, warm ischemia-damaged experimental liver grafts. Liver Transpl. 2012;18:219–225. doi: 10.1002/lt.22442. [DOI] [PubMed] [Google Scholar]
- 30.Minor T, Manekeller S. Assessment of hepatic integrity after ischemic preservation by isolated perfusion in vitro: The role of albumin. Cryobiology. 2007;54:188–195. doi: 10.1016/j.cryobiol.2007.01.002. [DOI] [PubMed] [Google Scholar]
- 31.Boyer JL. Bile formation and secretion. Compr Physiol. 2013;3:1035–1078. doi: 10.1002/cphy.c120027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil Infiltration As An Important Factor in Liver Ischemia and Reperfusion Injury. Transplantation. 1993;55:1265–1272. doi: 10.1097/00007890-199306000-00011. [DOI] [PubMed] [Google Scholar]
- 33.Funel N, Giovannetti E, Chiaro MD, Pollina L, Mosca F, Peters G, Campani D, Boggi U. Molecular mechanisms underlying the synergistic interaction of the novel anticancer drug celandine with gemcitabine in preclinical models of pancreatic cancer. Polski Tygodnik Lekarski. 2011;11:23–40. [Google Scholar]
- 34.Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
- 35.Sun K, Liu ZS, Sun Q. Role of mitochondria in cell apoptosis during hepaticischemia-reperfusion injury and protective effect of ischemic postconditioning. World J Gastroenterol. 2004;10:1934–1938. doi: 10.3748/wjg.v10.i13.1934. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Zhang L, Li C, Quan R, Xie S. The effect of electroacupuncture on neuronal apoptosis and related functions in rats with acute spinal cord injury. Chin Med. 2014;5:199–210. doi: 10.4236/cm.2014.54024. [DOI] [Google Scholar]
- 37.Radak Z, Zhao Z, Koltai E, Ohno H, Atalay M. Oxygen consumption and usage during physical exercise: The balance between oxidative stress and ROS-dependent adaptive signaling. Antioxid Redox Signal. 2013;18:1208–1246. doi: 10.1089/ars.2011.4498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Cardoso AR, Kakimoto PA, Kowaltowski AJ. Diet-sensitive sources of reactive oxygen species in liver mitochondria: Role of very long chain Acyl-CoA dehydrogenases. PLoS One. 2013;8:e77088. doi: 10.1371/journal.pone.0077088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic Biol Med. 2010;49:1603–1616. doi: 10.1016/j.freeradbiomed.2010.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Chao DT, Korsmeyer SJ. BCL-2 family: Regulators of cell death. Annu Rev Immunol. 1998;16:395–419. doi: 10.1146/annurev.immunol.16.1.395. [DOI] [PubMed] [Google Scholar]
- 41.Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74:609–619. doi: 10.1016/0092-8674(93)90509-O. [DOI] [PubMed] [Google Scholar]
- 42.Klune JR, Tsung A. Molecular biology of liver ischemia/reperfusion injury: Established mechanisms and recent advancements. Surg Clin North Am. 2010;90:665–677. doi: 10.1016/j.suc.2010.04.003. [DOI] [PubMed] [Google Scholar]
- 43.Weigand K, Brost S, Steinebrunner N, Büchler M, Schemmer P, Müller M. Ischemia/reperfusion injury in liver surgery and transplantation: Pathophysiology. HPB Surg. 2012;2012:176723. doi: 10.1155/2012/176723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Marecki H, Bozorgzadeh A, Porte RJ, Leuvenink HG, Uygun K, Martins PN. Liver ex situ machine perfusion preservation: A review of the methodology and results of large animal studies and clinical trials. Liver Transpl. 2017;23:679–695. doi: 10.1002/lt.24751. [DOI] [PubMed] [Google Scholar]
- 45.Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, Piña E, Geller DA. Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res. 2008;147:153–159. doi: 10.1016/j.jss.2007.06.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Kaczorowski DJ, Tsung A, Billiar TR. Innate immune mechanisms in ischemia/reperfusion. Front Biosci (Elite Ed) 2009;1:91–98. doi: 10.2741/E10. [DOI] [PubMed] [Google Scholar]
- 47.Zeng XP, Li XJ, Zhang QY, Liu QW, Li L, Xiong Y, He CX, Wang YF, Ye QF. Tert-Butylhydroquinone protects liver against ischemia/reperfusion injury in rats through Nrf2-activating anti-oxidative activity. Transplant Proc. 2017;49:366–372. doi: 10.1016/j.transproceed.2016.12.008. [DOI] [PubMed] [Google Scholar]
- 48.Tao X, Sun X, Xu L, Yin L, Han X, Qi Y, Xu Y, Zhao Y, Wang C, Peng J. Total flavonoids from Rosa laevigata Michx fruit ameliorates hepatic ischemia/reperfusion injury through inhibition of oxidative stress and inflammation in rats. Nutrients. 2016;8:E418. doi: 10.3390/nu8070418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Chou YH, Ho FM, Liu DZ, Lin SY, Tsai LH, Chen CH, Ho YS, Hung LF, Liang YC. The possible role of heat shock factor-1 in the negative regulation of heme oxygenase-1. Int J Biochem Cell Biol. 2005;37:604–615. doi: 10.1016/j.biocel.2004.08.006. [DOI] [PubMed] [Google Scholar]
- 50.Pastukh V, Ruchko M, Gorodnya O, Wilson GL, Gillespie MN. Sequence-specific oxidative base modifications in hypoxia-inducible genes. Free Radic Biol Med. 2007;43:1616–1626. doi: 10.1016/j.freeradbiomed.2007.08.027. [DOI] [PubMed] [Google Scholar]
- 51.Hsieh CY, Hsiao HY, Wu WY, Liu CA, Tsai YC, Chao YJ, Wang DL, Hsieh HJ. Regulation of shear-induced nuclear translocation of the Nrf2 transcription factor in endothelial cells. J Biomed Sci. 2009;16:12. doi: 10.1186/1423-0127-16-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.St Peter SD, Imber CJ, Friend PJ. Liver and kidney preservation by perfusion. Lancet. 2002;359:604–613. doi: 10.1016/S0140-6736(02)07749-8. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All data generated or analyzed during this study are included in this published article.